Skip to content

VirnetX Holding Corp VHC Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount

Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount at other companies

AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$1.5M-27.0%
CarGurus, Inc. logo
CarGurus, Inc.CARG
$980.25K
ESN
Essent GroupESNT
$79K-61.8%
Vertex, Inc. logo
Vertex, Inc.VERX
$1.13M-8.4%
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
$844.25K
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$330.75K-25.0%

Other financials

Income statement

See full
Revenue-
Operating income-$4.5M-11.4%
Net income-$4.4M-18.3%
EPS (diluted)-$1.16-14.9%

Balance sheet

See full
Cash & equivalents$14.8M-36.4%
Total debt$7.2M-10.8%
Total equity$18.9M-48.2%
Total assets$26.7M-40.8%

Cash flow

See full
Operating cash flow-$4.3M-10.3%
CapEx$17.0K
Free cash flow-$5.8M-5.2%

Valuation

See full
Market cap$53.16M+26.6%
Enterprise value$45.6M+39.7%
P/S328.2×-512×

Profitability

See full
Operating margin-12,284.6%-6,084pp
Net margin-11,666.7%-5,775pp
FCF margin-35,193.8%

Returns & leverage

See full
Return on equity-68.5%+181pp
Debt / equity0.4×+0.2×
Current ratio8.5×-9.2×

Where this comes from

Reported directly by VirnetX Holding Corp in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationTaxCreditsResearch.

The official record: VirnetX Holding Corp ’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about VirnetX Holding Corp 's effective income tax rate reconciliation, tax credit, research, amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is VirnetX Holding Corp 's effective income tax rate reconciliation, tax credit, research, amount?
VirnetX Holding Corp (VHC) reported effective income tax rate reconciliation, tax credit, research, amount of $90.75K in Q4 2025.
What does effective income tax rate reconciliation, tax credit, research, amount mean?
This represents the dollar value of tax credits claimed by the company specifically for qualifying research and development activities. It serves as a measure of government-provided tax incentives for innovation. A higher value indicates a greater utilization of R&D tax subsidies to reduce tax liabilities.